KORU Medical Systems Inc (KRMD) reports a 23% revenue increase and expands its international footprint, while addressing challenges in the immunoglobulin market.

Sees FY25 gross margin between 61% – 63%; Operational cash flow positive for the full year 2025. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news.

Reports Q4 revenue $8.8M, consensus $8.9M. “In 2024, we delivered strong performance and hit multiple key milestones,” said Linda Tharby, ...

The woman, Olivia Atamba, had gone to pick her form three daughter from Nyakongo Girls for half term break, and boarded the ...

Direxion Korea Bull ETF can yield significant gains during bull runs but can also incur substantial losses during downturns ...

We came across a bullish thesis on KORU Medical Systems, Inc. (KRMD) on Substack by Shareholdersunite. In this article, we ...

KORU Medical Systems (NASDAQ:KRMD – Get Free Report) is expected to issue its quarterly earnings data after the market closes on Wednesday, March 12th. Analysts expect the company to announce earnings ...

Piper Sandler has downgraded KORU Medical Systems (NASDAQ:KRMD) to neutral from overweight largely on valuation. The investment bank noted KORU's (NASDAQ:KRMD) valuation was "sitting near multi ...

The Nyaugenya bus was travelling from Usenge to Bondo, through Kisumu, en route to Nairobi along the Koru-Muhoroni highway ...

Jeff Bezos is set to marry Lauren Sanchez this summer, according to media reports. It is believed the couple will marry in a ...

MAHWAH, N.J., February 19, 2025--KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on development, manufacturing ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...